Raia Drogasil (RADLY) Expected to Announce Quarterly Earnings on Tuesday

Raia Drogasil (OTCMKTS:RADLY) will likely be posting its results after the market closes on Tuesday, August 4th. Analysts expect Raia Drogasil to announce earnings of $0.0471 per share and revenue of $2.3188 billion for the quarter.

Raia Drogasil Price Performance

Raia Drogasil stock remained flat at $3.87 during mid-day trading on Tuesday. 6,070 shares of the company’s stock traded hands, compared to its average volume of 56,822. The business has a 50 day moving average of $3.56 and a 200 day moving average of $4.27. Raia Drogasil has a 1-year low of $2.33 and a 1-year high of $5.34.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Raia Drogasil currently has a consensus rating of “Hold”.

Raia Drogasil Company Profile

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.